Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "D aspartate" patented technology

Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

ActiveUS12527799B2Organic active ingredientsNervous disorderCompulsive disordersNR1 NMDA receptor
Disclosed are methods for treating NMDA receptor-mediated disorders by administering certain NR2B subunit-selective NMDA (N methyl-D aspartate) antagonists. NMDA receptor-mediated disorders include autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders.
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
View all
Owner:RUGEN HLDG CAYMAN

Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

PendingUS20260199357A1Compulsive disordersNR1 NMDA receptor
Disclosed are methods for treating NMDA receptor-mediated disorders by administering certain NR2B subunit-selective NMDA (N methyl-D aspartate) antagonists. NMDA receptor-mediated disorders include autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders.
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
View all
Owner:RUGEN HLDG CAYMAN